Vice President of Translational Development, SRI International
Jon C. Mirsalis, Ph.D., D.A.B.T.
About the Speaker
Dr. Jon C. Mirsalis, Ph.D., D.A.B.T., is Vice President of Translational Development at SRI International in Menlo Park, CA. Dr. Mirsalis is an internationally recognized expert in the development of drugs for infectious diseases. He manages two large programs for the National Institute of Allergy and Infectious Diseases (NIAID) for the development of promising therapeutics for the prevention and treatment of a broad range of infectious diseases including TB, malaria, influenza, polio, anthrax, plague and Ebola. He has personally been involved in the development of over 50 therapeutics for cancer, infectious disease and CNS indications that have entered clinical trials and several have already reached the market. He is the author of nearly 200 publications and abstracts. Dr. Mirsalis holds Ph.D. degrees in toxicology and genetics from North Carolina State University. He lectures on biosecurity at Stanford University School of Medicine, is a past member of the FDA’s Over-the-Country Product Review Committee, and currently serves on the Board of Directors of the California Biomedical Research Association (2014-2017). Dr. Mirsalis has been certified by the American Board of Toxicology since 1983.
SRI International is a nonprofit research and development institute nearly a 70 year history working with academic, commercial, foundation and government clients and partners to bring new medicines, diagnostics and devices to market. Today, combining the approaches of a nonprofit research institute, a biotech venture, and a contract research organization (CRO), SRI integrates all of the R&D resources necessary to take drugs and vaccines from idea to the clinic.
- Be very afraid: the cultural response to terror, pandemics, environmental devastation, nuclear annihilation, and other threats
- Missing microbes: how the overuse of antibiotics is fueling our modern plagues
- The next pandemic: on the front lines against humankind's gravest dangers
- Pandemic: tracking contagions, from cholera to Ebola and beyond
- Zika: the emerging epidemic